Wednesday 4th July

9.00 – Biomarkers – Pietro Spitali and Andreas Roos

10.00 – Showcase: validation of MRI as a biomarker in clinical trials – Volker Straub


11.00 – Coffee/tea


11.30 – Showcase: PROM development – Nathalie Goemans


12.15 – Lunch


13.15 – Clinical trial practicality forum – moderated by Annemieke Aartsma-Rus and Teresinha Evangelista

16.30 – After approval: Proms and HTA – TBC

17.30 – End of day 3

supported by the

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are supported by the European Commission. For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern